DataMeds AI MEDS

DataMeds AI signs IP license deal

Form
8-K
Filed
Importance
Routine
  1. Signed IP License Agreement with REBOOT on Oct 13, 2026
  2. Received 666,667 shares of DataMeds stock valued at $2M
  3. Company increased equity to exceed $2.5M
  4. Nasdaq may confirm compliance with listing rules

Written from the 8-K on EDGAR. Check the filing before you rely on it.

Get an email when DataMeds AI files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 5122 and related industry codes: the same peer list as the financial tables.